---------- Forwarded message ----------
From: National Institutes of Health (NIH) <nih.ocpl@service.govdelivery.com>
Date: Mon, Aug 18, 2014 at 11:09 AM
Subject: NIH announces the launch of 3 integrated precision medicine trials
To: iammejtm@gmail.com
From: National Institutes of Health (NIH) <nih.ocpl@service.govdelivery.com>
Date: Mon, Aug 18, 2014 at 11:09 AM
Subject: NIH announces the launch of 3 integrated precision medicine trials
To: iammejtm@gmail.com
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
08/18/2014 01:07 PM EDT ALCHEMIST is for patients with certain types of early-stage lung cancer. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact NIHinfo@od.nih.gov. Before writing, please view our Frequently Asked Questions page, our A-Z Health Topics page, or Search our website. This service is provided to you by the National Institutes of Health.
|
Jeremy Tobias Matthews
No comments:
Post a Comment